Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
Singzyme works in Biotechnology, out of Singapore. Ownership is privately held; it publishes at singzyme.com. It holds one address on record, all in Singapore. The record counts 5 people. One Singapore registration (UEN) is a confirmed match. The record links nine similar brands, most of them in Biotechnology Research.
UEN202114449D
| SINGZYME PTE. LTD. | UEN 202114449D |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Singzyme's mission is to deliver on the promise of effective immuno-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide.
Singzyme applies its platform technology in the field of immuno-therapies with a focus on the conjugation of active molecules to protein carriers, for example, but not limited to Antibody-Drug Conjugates (ADCs).
Singzyme provides an integrated, high-speed, precision bio-manufacturing platform for ADCs and other bioconjugates.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. SINGZYME PTE. LTD. (UEN 202114449D), high confidence.
The record holds 5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Singapore only. Primary: Singapore.
None linked to this brand.
14 profiles list Singzyme as a peer — 89th percentile in Biotechnology. It lists ten peers of its own. CytoMed Therapeutics Limited and NexCalibur Therapeutics list it back.